CM082 in Patients With Myopic Choroidal Neovascularization (CNV)

Clinical trial NCT04222842 · SUSPENDED

Trial details

NCT number: NCT04222842
Sponsor: AnewPharma
Status: SUSPENDED
Phase: Phase 1
Study type: INTERVENTIONAL

Myopic Choroidal Neovascularisation

Start date: 2019-12-18
Primary completion: 2021-12-30
Enrollment: 96

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.